Mirimus is your trusted partner in preclinical drug discovery, providing robust testing and development services across a range of therapeutic areas. Whether your focus is on small molecules, biologics, RNAi-based therapeutics, or CRISPR gene editing, our experienced team is equipped to support the development and testing of your candidates. With a balance of expertise in in-house development and preclinical testing of client-provided compounds, we aim to accelerate your path to clinical success.
With a focus on both in-house development and client-provided compound testing, Mirimus offers a complete range of preclinical drug discovery services. Our expertise ensures that your small molecules, biologics, RNAi therapeutics, and CRISPR candidates are fully characterized, optimized, and ready for clinical advancement. Contact us today to learn how we can accelerate your drug discovery journey.
